BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 20703207)

  • 1. Update: Recommendations of the Advisory Committee on Immunization Practices (ACIP) regarding use of CSL seasonal influenza vaccine (Afluria) in the United States during 2010-11.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Aug; 59(31):989-92. PubMed ID: 20703207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influenza vaccine safety in children less than 5 years old: the 2010 and 2011 experience in Australia.
    Wood N; Sheppeard V; Cashman P; Palasanthiran P; Casacelli M; Cannings K; McIntyre P
    Pediatr Infect Dis J; 2012 Feb; 31(2):199-202. PubMed ID: 22094632
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adverse events after inactivated influenza vaccination among children less than 2 years of age: analysis of reports from the vaccine adverse event reporting system, 1990-2003.
    McMahon AW; Iskander J; Haber P; Chang S; Woo EJ; Braun MM; Ball R
    Pediatrics; 2005 Feb; 115(2):453-60. PubMed ID: 15687455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Signal identification and evaluation for risk of febrile seizures in children following trivalent inactivated influenza vaccine in the Vaccine Safety Datalink Project, 2010-2011.
    Tse A; Tseng HF; Greene SK; Vellozzi C; Lee GM;
    Vaccine; 2012 Mar; 30(11):2024-31. PubMed ID: 22361304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP)--United States, 2012-13 influenza season.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2012 Aug; 61(32):613-8. PubMed ID: 22895385
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2017-18 Influenza Season.
    Grohskopf LA; Sokolow LZ; Broder KR; Walter EB; Bresee JS; Fry AM; Jernigan DB
    MMWR Recomm Rep; 2017 Aug; 66(2):1-20. PubMed ID: 28841201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Seasonal influenza vaccination coverage among children aged 6 months-18 years --- eight immunization information system sentinel sites, United States, 2009-10 influenza season.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2010 Oct; 59(39):1266-9. PubMed ID: 20930704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2011.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Aug; 60(33):1128-32. PubMed ID: 21866086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices - United States, 2019-20 Influenza Season.
    Grohskopf LA; Alyanak E; Broder KR; Walter EB; Fry AM; Jernigan DB
    MMWR Recomm Rep; 2019 Aug; 68(3):1-21. PubMed ID: 31441906
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influenza vaccination coverage among children aged 6 months--18 years - eight immunization information system sentinel sites, United States, 2008-09 influenza season.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2009 Oct; 58(38):1059-62. PubMed ID: 19798018
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices-United States, 2018-19 Influenza Season.
    Grohskopf LA; Sokolow LZ; Broder KR; Walter EB; Fry AM; Jernigan DB
    MMWR Recomm Rep; 2018 Aug; 67(3):1-20. PubMed ID: 30141464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantifying benefits and risks of vaccinating Australian children aged six months to four years with trivalent inactivated seasonal influenza vaccine in 2010.
    Kelly H; Carcione D; Dowse G; Effler P
    Euro Surveill; 2010 Sep; 15(37):. PubMed ID: 20929647
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reactogenicity of two 2010 trivalent inactivated influenza vaccine formulations in adults.
    Leeb A; Carcione D; Richmond PC; Jacoby P; Effler PV
    Vaccine; 2011 Oct; 29(45):7920-4. PubMed ID: 21864621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Febrile events including convulsions following the administration of four brands of 2010 and 2011 inactivated seasonal influenza vaccine in NZ infants and children: the importance of routine active safety surveillance.
    Petousis-Harris H; Poole T; Turner N; Reynolds G
    Vaccine; 2012 Jul; 30(33):4945-52. PubMed ID: 22664224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the bioactivity of influenza vaccine strains in vitro suggests that the introduction of new strains in the 2010 Southern Hemisphere trivalent influenza vaccine is associated with adverse events.
    Rockman S; Dyson A; Koernig S; Becher D; Ng M; Morelli AB; Barnden M; Tang ML; Pearse M; Maraskovsky E
    Vaccine; 2014 Jun; 32(30):3861-8. PubMed ID: 24928062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fever following administration of two inactivated influenza vaccines--a survey of parents of New Zealand infants and children 5 years of age and under.
    Petousis-Harris H; Poole T; Booy R; Turner N
    Vaccine; 2011 Apr; 29(16):2933-7. PubMed ID: 21338679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010.
    Fiore AE; Uyeki TM; Broder K; Finelli L; Euler GL; Singleton JA; Iskander JK; Wortley PM; Shay DK; Bresee JS; Cox NJ;
    MMWR Recomm Rep; 2010 Aug; 59(RR-8):1-62. PubMed ID: 20689501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24-59 months in the United States.
    Luce BR; Nichol KL; Belshe RB; Frick KD; Li SX; Boscoe A; Rousculp MD; Mahadevia PJ
    Vaccine; 2008 Jun; 26(23):2841-8. PubMed ID: 18462851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention and Control of Seasonal Influenza with Vaccines: Recommendations of the Advisory Committee on Immunization Practices, United States, 2021-22 Influenza Season.
    Grohskopf LA; Alyanak E; Ferdinands JM; Broder KR; Blanton LH; Talbot HK; Fry AM
    MMWR Recomm Rep; 2021 Aug; 70(5):1-28. PubMed ID: 34448800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serious adverse events rarely reported after trivalent inactivated influenza vaccine (TIV) in children 6-23 months of age.
    Rosenberg M; Sparks R; McMahon A; Iskander J; Campbell JD; Edwards KM
    Vaccine; 2009 Jul; 27(32):4278-83. PubMed ID: 19450636
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.